Home
Deutsch
Advanced Search
Browse by ...
Publication overview
Contact persons
Help
Publ. Version/Full Text
DOI
PMC
 |
Open Access Gold |
|
as soon as is submitted to ZB.
State-of-the-art laser ablation for cardiac arrhythmias: Development and future perspective-a state-of-the-art review.
J. Innov. Card. Rhythm. Manag. 16, 6529-6550 (2025)
Cardiovascular laser application (CVLA) is an innovative approach in the field of cardiology aimed at treating various cardiovascular diseases, including cardiac arrhythmias, cardiomyopathies, systemic and pulmonary resistant hypertension, and varicose leg veins, by using a key technology, the laser. Tissue-selective photon absorption of the 1064-nm wavelength induces tissue-selective irreversible lesions of arrhythmogenic myocardium, modulation of retrocardiac ganglion plexi, and renal and pulmonary perivascular innervation. This review summarizes the development and the experimental and clinical results of the CVLA, highlighting its potential advantages over other catheter ablation methods. Based on its unique characteristics, laser treatment has the potential to become an all-pervasive, safe, and effective procedure for the benefit of countless patients.
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Review
Keywords
1064-nm Laser ; Atrial Fibrillation ; Cardiac Arrhythmias ; Ganglion Plexi ; Laser Catheter Ablation
ISSN (print) / ISBN
2156-3977
e-ISSN
2156-3993
Quellenangaben
Volume: 16,
Issue: 12,
Pages: 6529-6550
Publisher
MediaSphere Medical LLC
Reviewing status
Peer reviewed
Institute(s)
CF Laboratory Animal Services (CF-LAS)
Cooperation Group Comprehensive Molecular Analytics (CMA)
Cooperation Group Comprehensive Molecular Analytics (CMA)